Who invested in Triveni Bio?
Triveni Bio's investors include Polaris Partners, OrbiMed, Cormorant Asset Management, Goldman Sachs and Atlas Venture, and 2 more on record.

United States · Series C startup
Funding summaryUpdated 26 Oct 2026
$180Mraised across 2 rounds since 2024, from 2 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Source recorded
Source recorded
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Triveni Bio's investors include Polaris Partners, OrbiMed, Cormorant Asset Management, Goldman Sachs and Atlas Venture, and 2 more on record.
Triveni Bio has raised $180M across 2 rounds since 2024.
Triveni Bio's most recent round was a Series C of $65M in Jun 2026.
Triveni Bio's largest round on record is $115M (Series B), in Oct 2024.
Triveni Bio's first round on record, in Oct 2024, was backed by Atlas Venture, Polaris Partners and OrbiMed and 2 others.
Triveni Bio's latest named round is a Series C, in Jun 2026.
Triveni Bio is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.